SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Alternative Medicine/Health
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote ()10/9/1999 1:46:00 PM
From: scaram(o)uche   of 357
 
biz.yahoo.com

According to Juan Alvarez, M.D., Ph.D., and Steven Freedman, M.D., Ph.D., of Beth Israel Deaconess, a reversible
imbalance between two fatty acids found in cell membranes may be responsible for the common symptoms of cystic fibrosis.
Alvarez and Freedman reported they were able to reverse signs of the disease by correcting the imbalance in mice carrying the
genetic defect that causes cystic fibrosis. The researchers corrected the imbalance by feeding the mice one of the fatty acids
known as DHA. They also said that preliminary evidence shows a similar lipid imbalance exists in people with cystic fibrosis.

Genzyme is working to develop a therapeutically effective formulation for a DHA-based product designed to correct the lipid
imbalance in cystic fibrosis patients and alleviate the chronic lung inflammation, excess mucus, and other symptoms of the
disease. Genzyme plans to initiate clinical trials of a DHA- based product within a year and expects to conduct its trials in
collaboration with the Cystic Fibrosis Foundation, which has a specialized network of medical research centers to expedite the
early phases of clinical trials.

Please get the word out to all affected families. Don't know where this is going and don't know what "therapeutically effective formulation" means, but DHA is commonly available right now.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News